Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal, and peritoneal carcinoma
    Meeting Abstract

    Zivanovic, O.; Chi, D. S.; Eisenhauer, E. L.; Sonoda, Y.; Levine, D. A.; Brown, C. L.; Barakat, R. R.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Reporting of clinical trial data: Are we fully utilizing the current clinical trial data to help manage the older adult cancer population?
    Meeting Abstract

    Tam-McDevitt, J. T.; Tew, W.; Klapper, S.; Hauser, R.; Lichtman, S.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • VEGF-Trap for patients (pts) with recurrent platinum-resistant epithelial ovarian cancer (EOC): Preliminary results of a randomized, multicenter phase II study
    Meeting Abstract

    Tew, W. P.; Colombo, N.; Ray-Coquard, I.; Oza, A.; del Campo, J.; Scambia, G.; Spriggs, D.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase II trial of single-agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash
    Meeting Abstract

    Schilder, R. J.; Lokshin, A. E.; Holloway, R. W.; Alvarez, R. D.; Pathak, H.; Aghajanian, C.; Drescher, C. W.; Godwin, A. K.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Impact of risk-reducing oophorectomy on quality of life in women at risk for ovarian cancer
    Meeting Abstract

    McArthur, H. L.; Hensley, M.; Brown, C. L.; Chi, D. S.; Offit, K.; Hurley, K.; Li, Y.; Gemignani, M. L.; Robson, M. E.; Barakat, R. R.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The role of surgery in high-risk gestational trophoblastic disease patients
    Meeting Abstract

    Lewin, S. N.; Soslow, R. A.; Kim, M. J.; Derosa, F. A.; Abu-Rustum, N. R.; Sonoda, Y.; Brown, C. L.; Baines, M. S.; Flores, R.; Aghajanian, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel (Tax), IP cisplatin (Cis), and IV bevacizumab (Bev) as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
    Meeting Abstract

    Konner, J. A.; Fallon, K.; Pezzuli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Chiang, A.; Tew, W.; Spriggs, D.; Aghajanian, C.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I trial of PTK787/ZK222584 (PTK/ZK) in combination with carboplatin (C) and paclitaxel (T) in platinum-sensitive recurrent epithelial ovarian (EOC), fallopian tube (FT), or primary peritoneal (PPC) cancers
    Meeting Abstract

    Juretzka, M. M.; Aghajanian, C.; Hensley, M. L.; Tew, W. P.; Spriggs, D.; Konner, J.; Chiang, A. C.; Pezzulli, S.; Kim, M.; Sabbatini, P.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase 2 dose multi-center, open-label study of ARQ 501, a checkpoint activator, in adult patients with persistent, recurrent or metastatic leiomyosarcoma (LMS)
    Meeting Abstract

    Hartner, L. P.; Rosen, L.; Hensley, M.; Mendelson, D.; Staddon, A. P.; Chow, W.; Kovalyov, O.; Ruka, W.; Skladowski, K.; Jagiello-Gruszfeld, A.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of pemetrexed (P) plus gemcitabine (G) in advanced solid tumors (ST)
    Meeting Abstract

    Fury, M. G.; Larkin, J.; Gerst, S. R.; Sabbatini, P.; Konner, J.; Orlando, M.; Tai, D. F.; Goss, T.; Aghajanian, C.; Hensley, M. L.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save